Literature DB >> 26119044

Diverse functional outcomes of Plasmodium falciparum ligation of EPCR: potential implications for malarial pathogenesis.

Mark R Gillrie1, Marion Avril2, Andrew J Brazier2, Shevaun P Davis1, Monique F Stins3, Joseph D Smith2,4, May Ho1.   

Abstract

Plasmodium falciparum-infected erythrocytes (IRBC) expressing the domain cassettes (DC) 8 and 13 of the cytoadherent ligand P. falciparum erythrocyte membrane protein 1 adhere to the endothelial protein C receptor (EPCR). By interfering with EPCR anti-coagulant and pro-endothelial barrier functions, IRBC adhesion could promote coagulation and vascular permeability that contribute to the pathogenesis of cerebral malaria. In this study, we examined the adhesion of DC8- and DC13-expressing parasite lines to endothelial cells from different microvasculature, and the consequences of EPCR engagement on endothelial cell function. We found that IRBC from IT4var19 (DC8) and IT4var07 (DC13) parasite lines adhered to human brain, lung and dermal endothelial cells under shear stress. However, the relative contribution of EPCR to parasite cytoadherence on different types of endothelial cell varied. We also observed divergent functional outcomes for DC8 cysteine-rich interdomain region (CIDR)α1.1 and DC13 CIDRα1.4 domains. IT4var07 CIDRα1.4 inhibited generation of activated protein C (APC) on lung and dermal endothelial cells and blocked the APC-EPCR binding interaction on brain endothelial cells. IT4var19 CIDRα1.1 inhibited thrombin-induced endothelial barrier dysfunction in lung endothelial cells, whereas IT4var07 CIDRα1.4 inhibited the protective effect of APC on thrombin-induced permeability. Overall, these findings reveal a much greater complexity of how CIDRα1-expressing parasites may modulate malaria pathogenesis through EPCR adhesion.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26119044      PMCID: PMC4661070          DOI: 10.1111/cmi.12479

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  38 in total

1.  Synergism of multiple adhesion molecules in mediating cytoadherence of Plasmodium falciparum-infected erythrocytes to microvascular endothelial cells under flow.

Authors:  B G Yipp; S Anand; T Schollaardt; K D Patel; S Looareesuwan; M Ho
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

2.  Widespread functional specialization of Plasmodium falciparum erythrocyte membrane protein 1 family members to bind CD36 analysed across a parasite genome.

Authors:  Bridget A Robinson; Teresa L Welch; Joseph D Smith
Journal:  Mol Microbiol       Date:  2003-03       Impact factor: 3.501

3.  Identification of the protein C/activated protein C binding sites on the endothelial cell protein C receptor. Implications for a novel mode of ligand recognition by a major histocompatibility complex class 1-type receptor.

Authors:  P C Liaw; T Mather; N Oganesyan; G L Ferrell; C T Esmon
Journal:  J Biol Chem       Date:  2000-11-30       Impact factor: 5.157

4.  Human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway.

Authors:  Z Laszik; A Mitro; F B Taylor; G Ferrell; C T Esmon
Journal:  Circulation       Date:  1997-11-18       Impact factor: 29.690

5.  Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration.

Authors:  G G MacPherson; M J Warrell; N J White; S Looareesuwan; D A Warrell
Journal:  Am J Pathol       Date:  1985-06       Impact factor: 4.307

6.  Bacterial invasion and transcytosis in transfected human brain microvascular endothelial cells.

Authors:  M F Stins; J Badger; K Sik Kim
Journal:  Microb Pathog       Date:  2001-01       Impact factor: 3.738

7.  Analysis of adhesive domains from the A4VAR Plasmodium falciparum erythrocyte membrane protein-1 identifies a CD36 binding domain.

Authors:  J D Smith; S Kyes; A G Craig; T Fagan; D Hudson-Taylor; L H Miller; D I Baruch; C I Newbold
Journal:  Mol Biochem Parasitol       Date:  1998-11-30       Impact factor: 1.759

8.  Differentiating the pathologies of cerebral malaria by postmortem parasite counts.

Authors:  Terrie E Taylor; Wenjiang J Fu; Richard A Carr; Richard O Whitten; Jeffrey S Mueller; Nedson G Fosiko; Susan Lewallen; N George Liomba; Malcolm E Molyneux; Jeffrey G Mueller
Journal:  Nat Med       Date:  2004-01-25       Impact factor: 53.440

9.  Recombinant PfEMP1 peptide inhibits and reverses cytoadherence of clinical Plasmodium falciparum isolates in vivo.

Authors:  Bryan G Yipp; Dror I Baruch; Ciaran Brady; Allan G Murray; Sornchai Looareesuwan; Paul Kubes; May Ho
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

10.  Structural conservation despite huge sequence diversity allows EPCR binding by the PfEMP1 family implicated in severe childhood malaria.

Authors:  Clinton K Y Lau; Louise Turner; Jakob S Jespersen; Edward D Lowe; Bent Petersen; Christian W Wang; Jens E V Petersen; John Lusingu; Thor G Theander; Thomas Lavstsen; Matthew K Higgins
Journal:  Cell Host Microbe       Date:  2014-12-04       Impact factor: 21.023

View more
  38 in total

1.  Rupture and Release: A Role for Soluble Erythrocyte Content in the Pathology of Cerebral Malaria.

Authors:  Julio Gallego-Delgado; Ana Rodriguez
Journal:  Trends Parasitol       Date:  2017-07-11

2.  Breaking down brain barrier breaches in cerebral malaria.

Authors:  Jens E V Petersen; Thomas Lavstsen; Alister Craig
Journal:  J Clin Invest       Date:  2016-09-19       Impact factor: 14.808

3.  The Severity of Plasmodium falciparum Infection Is Associated with Transcript Levels of var Genes Encoding Endothelial Protein C Receptor-Binding P. falciparum Erythrocyte Membrane Protein 1.

Authors:  Sixbert I Mkumbaye; Christian W Wang; Eric Lyimo; Jakob S Jespersen; Alphaxard Manjurano; Jacklin Mosha; Reginald A Kavishe; Steven B Mwakalinga; Daniel T R Minja; John P Lusingu; Thor G Theander; Thomas Lavstsen
Journal:  Infect Immun       Date:  2017-03-23       Impact factor: 3.441

Review 4.  Malaria link of hypertension: a hidden syndicate of angiotensin II, bradykinin and sphingosine 1-phosphate.

Authors:  Gunanidhi Dhangadamajhi; Shailja Singh
Journal:  Hum Cell       Date:  2021-03-08       Impact factor: 4.174

5.  Testing the effect of PAR1 inhibitors on Plasmodium falciparum-induced loss of endothelial cell barrier function.

Authors:  Janet Storm; Yang Wu; Christopher A Moxon; Alister G Craig; Jill Davies
Journal:  Wellcome Open Res       Date:  2020-07-07

Review 6.  Opportunities for Host-targeted Therapies for Malaria.

Authors:  Elizabeth K K Glennon; Selasi Dankwa; Joseph D Smith; Alexis Kaushansky
Journal:  Trends Parasitol       Date:  2018-08-16

Review 7.  EPCR and Malaria Severity: The Center of a Perfect Storm.

Authors:  Maria Bernabeu; Joseph D Smith
Journal:  Trends Parasitol       Date:  2016-12-06

Review 8.  The role of EPCR in the pathogenesis of severe malaria.

Authors:  Laurent O Mosnier; Thomas Lavstsen
Journal:  Thromb Res       Date:  2016-05       Impact factor: 3.944

Review 9.  Severe malaria: what's new on the pathogenesis front?

Authors:  Samuel Crocodile Wassmer; Georges Emile Raymond Grau
Journal:  Int J Parasitol       Date:  2016-09-23       Impact factor: 3.981

10.  Severe adult malaria is associated with specific PfEMP1 adhesion types and high parasite biomass.

Authors:  Maria Bernabeu; Samuel A Danziger; Marion Avril; Marina Vaz; Prasad H Babar; Andrew J Brazier; Thurston Herricks; Jennifer N Maki; Ligia Pereira; Anjali Mascarenhas; Edwin Gomes; Laura Chery; John D Aitchison; Pradipsinh K Rathod; Joseph D Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.